Tuberculosis remains a major global health threat, requiring innovative solutions and evidence-based practices. In this session, our expert Dr. Trupti Gilada will share the latest trends, research, and clinical applications in TB management, empowering healthcare professionals to improve patient outcomes. Healthcare professionals will gain valuable insights into the evolving landscape of TB care, enabling them to improve patient outcomes and contribute to the global effort to combat this devastating disease.

Current Trends in Management of Tuberculosis

Mpox, also known as monkeypox, is an infectious disease caused by the monkeypox virus, a member of the Orthopoxvirus genus. A distinctive feature of the disease is the development of a rash that progresses through stages from macules to papules, vesicles, pustules, and scabs. Mpox is transmitted through direct contact with infectious lesions, body fluids, or contaminated materials, and can also spread through respiratory droplets. Effective management of Mpox involves supportive care and, in some cases, antiviral treatment. Preventive measures include isolation of infected individuals, use of personal protective equipment, and vaccination for high-risk populations. Enhance your understanding of Mpox with our expert session led by Dr. Trupti Gilada, who will provide comprehensive insights into the disease's clinical features, diagnosis, and management strategies.

The Ultimate Guide to Mpox: Everything You Need to Know

Join Dr Mahadev Desai in the latest episode of Changing Practice: June Roundup as we explore June's groundbreaking medical advancements. From cancer research to cardiovascular innovations, stay informed on the latest trends. In this episode, we discuss the latest on fluid therapy for critically ill adults with sepsis, posterior reversible encephalopathy syndrome, megaloblastic anemia presenting as pyrexia & WHO's recent warning on sugar substitutes. Share this #MustAttendSession with colleagues and tune in to Medflix for a blockbuster discussion on medical progress!

Changing Practice: June Roundup!

In some regions of the world, cholera continues to be one of the deadliest diseases, ranking among the most dreaded in human history. Since originating in India 200 years ago, it has been the cause of seven pandemics that have killed millions of people. While most people with cholera will have no symptoms or rather moderate ones, about 1 in 10 people will experience serious symptoms such as severe watery diarrhea, vomiting, and muscle cramps. If left untreated, cholera can be fatal within hours. The WHO has issued a warning regarding the resurgence of one of Humanity’s Most Feared Killers, cholera. Join us live to understand the updates and get ready for this with Dr. Trupti Gilada.

Cholera : An Unwelcome Comeback

TB & HIV co-infection represents a novel pathogenic scenario at the global level. It constitutes a serious diagnostic and therapeutic challenge, particularly in poor countries. Infection with HIV is the most powerful known risk factor predisposing for Mycobacterium tuberculosis infection and progression to active disease, which increases the risk of latent TB reactivation 20-fold. TB is also the most common cause of AIDS-related death. Join this intriguing session live with Dr. Trupti Gilada where she describes how to systematically approach a case of TB & HIV coinfection!

Approach to Tuberculosis & HIV Coinfection

Our body is constantly being exposed to numerous pathogens like bacteria, virus, fungi and protozoa. However, the immune system in our body prevents the pathogens from invading and causing illness. But when the immunity is weakened, these organisms avail the opportunity to invade and to cause severe illness. Many opportunistic infections are acquired in hospital. They are a major cause of illness and death in oncology patients and are the leading cause of death in recipients of renal transplants. Severely immunocompromised patients may develop simultaneous infections with several different types of opportunist organisms and are the usual cause of death in patients with AIDS. The diagnosis and appropriate management of opportunistic infections poses a great dilemma to the clinicians. Learn all you need to know about these infections live with Dr. Trupti Gilada!

Opportunistic Infections: A Diagnostic Dilemma

Consultant Physician Internal Medicine, Unison Medicare & Research Centre | Fellowship Infectious Diseases, Harvard University | Fellowship HIV/AIDS, Fred Hutchinson Centre

Dr. Trupti Gilada

6

3.5k

67.8k

4.7

Sessions Taken

1.9k

4.7

726

4.8

1.1k

4.8

704

4.7

1.3k

4.5

409

4.5